FDA Approves First Cannabis-Based Epilepsy Drug

fda-logo

MARYLAND: The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…

America’s Drug Companies Are Bankrolling The Crusade Against Legal Weed

Although the government had initially been aiming for year-end, marijuana could start being sold from pharmacies in March.

As more U.S. states legalize marijuana, special interest groups that have a financial stake in the fight have been pushing back under the guise of fighting drug abuse. Last week, The Nation published an interesting look at who’s driving the fight against the legalization of marijuana. Pharmaceutical companies that make billions off painkillers and police unions are Read the full article…

Pharmaceutical Companies Don’t Want Marijuana Legalized

Lawmakers are moving ahead with legislative efforts to allow for the limited use of medical ‘cannabis’ while simultaneously forbidding anyone from either inhaling the herb or possessing its flowers.

I can see why pharmaceutical companies don’t want marijuana legalized. Take a $4 blood pressure pill with a glass of grapefruit juice, and you might get the effects of $1.75 of that medicine. Wow, with a whopping 47% of medicine ineffectiveness, it seems like a giant waste of money for a product that won’t do you any Read the full article…

Pharmaceutical Companies Don’t Want Marijuana Legalized

Why can’t we pile on the money for cancer research with marijuana! Regulating blood pressure with marijuana, halting mood swings and depression, the list gets longer every day!  The beneficial effects of this plant are just beginning to surface. With REAL research and development, this may just be the new “Super Drug” that will replace many of our older medications, the ones with vast side effects and contraindications. Even doctors agree some medications need to be retired.

I can see why pharmaceutical companies don’t want marijuana legalized. Take a $4 blood pressure pill with a glass of grapefruit juice, and you might get the effects of $1.75 of that medicine. Wow, with a whopping 47% of medicine ineffectiveness, it seems like a giant waste of money for a product that won’t do you any Read the full article…

NASP Launches Taskforce To Address Management Of Medical Marijuana

"Medical marijuana has come to the forefront of patient care in many of the diseases that Specialty Pharmacists treat including Multiple Sclerosis, Cancer, HIV and others,” Gary M. Cohen

VIRGINIA: The National Association of Specialty Pharmacy (NASP) has launched a taskforce to investigate the pharmacological management of medical marijuana, a growing issue for Specialty Pharmacists as the number of patients with chronic diseases continue to rise. 

NASP Launches Taskforce To Address Management Of Medical Marijuana

"Medical marijuana has come to the forefront of patient care in many of the diseases that Specialty Pharmacists treat including Multiple Sclerosis, Cancer, HIV and others,” Gary M. Cohen

VIRGINIA: The National Association of Specialty Pharmacy (NASP) has launched a taskforce to investigate the pharmacological management of medical marijuana, a growing issue for Specialty Pharmacists as the number of patients with chronic diseases continue to rise. 

Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives

Oregon city approves taxes on medical and recreational marijuana.

CANADA: Easton Pharmaceuticals, Inc. (OTC:EAPH), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announced updates to its Canadian and United States Medical Marijuana initiatives.

Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More

British pharma company makes big bet on cannabis

UNITED KINGDOM: Medicinal marijuana advocates contend that smoking pot helps relieve pain and alleviate nausea. British drug company GW Pharmaceuticals (GWP:LN) is betting that medicine made from cannabis can also treat maladies as diverse as diabetes, colitis, and epilepsy.